NCT04486794 is a NA clinical trial of Restylane® in Tear Trough Eyelid Deformity, sponsored by Erevna Innovations Inc..

Who is sponsoring NCT04486794?

NCT04486794 is sponsored by Erevna Innovations Inc..

What drugs are being tested in NCT04486794?

Interventions in NCT04486794: Restylane®.

What condition does NCT04486794 study?

NCT04486794 studies Tear Trough Eyelid Deformity.

Is NCT04486794 still recruiting?

NCT04486794 is currently completed. Last updated 10 February 2021.

Last reviewed 2021-02-10 · How we verify

NCT04486794

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Restylane® for the Treatment of Tear Trough Deformity

Completed NA Last updated 10 February 2021

What this trial tests

NA trial testing Restylane® in Tear Trough Eyelid Deformity in 42 participants. Completed in 31 December 2020.

Timeline

7 July 2019

Primary endpoint
30 December 2020

31 December 2020

Quick facts

Lead sponsor	Erevna Innovations Inc.
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	single
Primary purpose	treatment
Enrollment	42
Start date	7 July 2019
Primary completion	30 December 2020
Estimated completion	31 December 2020
Sites	1 location across Canada

Drugs / interventions tested

Restylane®

Conditions studied

Tear Trough Eyelid Deformity — all drugs for Tear Trough Eyelid Deformity →

Sponsor

Erevna Innovations Inc. — full company profile →

Who can join

18 and older, female only, with Tear Trough Eyelid Deformity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effectiveness and tolerability of Restylane® for correction of tear trough deformity, using various injection techniques.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Restylane®

Trials testing the same drug.

NCT02558283 — A Safety and Efficacy Study of JUVÉDERM® VOLIFT® With Lidocaine and Restylane® for Nasolabial Folds in Chinese Adults · NA · completed

Other Erevna Innovations Inc. trials

Trials by the same sponsor.

NCT07383766 — Aesthetic Improvement of Facial Rhytids Using Injectables · Phase 4 · recruiting
NCT07368686 — Topical Multivitamin Serum for Skin Heath · Phase 4 · recruiting
NCT07210190 — Microneedling for Skin Heath · Phase 4 · recruiting
NCT07079397 — Hyaluronic Acid Filler Migration · NA · recruiting
NCT07202117 — PLLA and CaHA-R for Aesthetic Rejuvenation · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04486794 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Erevna Innovations Inc.
Last refreshed: 10 February 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04486794.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing